Our guest this week is Stacey Shulman, Vice President Internet of Things Group / GM Health, Life Sciences and Emerging Technologies at Intel Corporation. In this episode, Stacey discusses where she sees AI make its way into healthcare now, how Covid has affected how adoption has been prioritized, and its consequences in the future. Stacey’s insights about how healthcare is evolving are correlated to how other enterprises are also adjusting their strategies or potentially should be in the setting of the ongoing pandemic. If you’re interested in unlocking our AI best practice guides, frameworks for AI ROI, and specific resources for AI consultants, visit emerj.com/p1.